The Involvement of Heat-Shock Proteins in the Pathogenesis of Autoimmune Arthritis: A Critical Appraisal

Seminars in Arthritis and Rheumatism

Volumn 40, Issue 2, 2010, Pages 164-175

  Huang, Min Nung ^a   Yu, Hua ^a   Moudgil, Kamal D ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Animal models; Heat shock proteins; Immune response; Pathogenesis; Rheumatoid arthritis

Indexed keywords

HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 10; HEAT SHOCK PROTEIN 22; HEAT SHOCK PROTEIN 32; HEAT SHOCK PROTEIN 40; HEAT SHOCK PROTEIN 47; HEAT SHOCK PROTEIN 60; HEAT SHOCK PROTEIN 65; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90; HEAT SHOCK PROTEIN 90 INHIBITOR; HLA DR4 ANTIGEN; SNX 4414; SNX 7081; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ADJUVANT ARTHRITIS; ANTIBODY RESPONSE; ANTIBODY TITER; ARTHRITIS; AUTOIMMUNITY; CHRONIC INFLAMMATION; CYTOKINE RELEASE; DISEASE ACTIVITY; DISEASE SEVERITY; ENVIRONMENTAL FACTOR; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOPATHOGENESIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; T LYMPHOCYTE ACTIVATION;

ANIMALS; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; DISEASE MODELS, ANIMAL; HEAT-SHOCK PROTEINS; HUMANS; IMMUNITY, ACTIVE;

EID: 77957018293     PISSN: 00490172     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semarthrit.2009.10.002     Document Type: Review

References (149)

1. Lipsky P.E. Rheumatoid arthritis. Harrison's Principles of Internal Medicine 2005, 1968-1977. McGraw-Hill, New York (NY). 16th edition. D. Kasper, E. Braunwald, A. Fauci, S. Hauser, D. Longo, J. Jameson (Eds.).
2. Lawrence R.C., Helmick C.G., Arnett F.C., Deyo R.A., Felson D.T., Giannini E.H., et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum 1998, 41(5):778-799.
3. Harris E.D. Rheumatoid arthritis. Pathophysiology and implications for therapy. N Engl J Med 1990, 322(18):1277-1289.
4. Lindquist S., Craig E.A. The heat-shock proteins. Annu Rev Genet 1988, 22:631-677.
5. Ranson N.A., White H.E., Saibil H.R. Chaperonins Biochem J 1998, 333(Pt. 2):233-242.
6. Srivastava P. Roles of heat-shock proteins in innate and adaptive immunity. Nat Rev Immunol 2002, 2(3):185-194.
7. Chang H.C., Tang Y.C., Hayer-Hartl M., Hartl F.U. SnapShot: molecular chaperones. Part I. Cell 2007, 128(1):212.
8. Holoshitz J., Naparstek Y., Ben-Nun A., Cohen I.R. Lines of T lymphocytes induce or vaccinate against autoimmune arthritis. Science 1983, 219(4580):56-58.
9. van Eden W., Thole J.E., van der Zee R., Noordzij A., van Embden J.D., Hensen E.J., et al. Cloning of the mycobacterial epitope recognized by T lymphocytes in adjuvant arthritis. Nature 1988, 331(6152):171-173.
10. Quintana F.J., Carmi P., Mor F., Cohen I.R. Inhibition of adjuvant arthritis by a DNA vaccine encoding human heat shock protein 60. J Immunol 2002, 169(6):3422-3428.
11. Moudgil K.D., Chang T.T., Eradat H., Chen A.M., Gupta R.S., Brahn E., et al. Diversification of T cell responses to carboxy-terminal determinants within the 65-kD heat-shock protein is involved in regulation of autoimmune arthritis. J Exp Med 1997, 185(7):1307-1316.
12. Ulmansky R., Cohen C.J., Szafer F., Moallem E., Fridlender Z.G., Kashi Y., et al. Resistance to adjuvant arthritis is due to protective antibodies against heat shock protein surface epitopes and the induction of IL-10 secretion. J Immunol 2002, 168(12):6463-6469.
13. Thompson S.J., Butcher P.D., Patel V.K., Rook G.A., Stanford J., van der Zee R., et al. Modulation of pristane-induced arthritis by mycobacterial antigens. Autoimmunity 1991, 11(1):35-43.
14. van den Broek M.F., Hogervorst E.J., Van Bruggen M.C., Van Eden W., van der Zee R., van den Berg W.B. Protection against streptococcal cell wall-induced arthritis by pretreatment with the 65-kD mycobacterial heat shock protein. J Exp Med 1989, 170(2):449-466.
15. Mia M.Y., Durai M., Kim H.R., Moudgil K.D. Heat shock protein 65-reactive T cells are involved in the pathogenesis of non-antigenic dimethyl dioctadecyl ammonium bromide-induced arthritis. J Immunol 2005, 175(1):219-227.
16. Francis J.N., Lamont A.G., Thompson S.J. The route of administration of an immunodominant peptide derived from heat-shock protein 65 dramatically affects disease outcome in pristane-induced arthritis. Immunology 2000, 99(3):338-344.
17. Hromadnikova I., Nguyen T.T., Zlacka D., Sedlackova L., Popelka S., Veigl D., et al. Expression of heat shock protein receptors on fibroblast-like synovial cells derived from rheumatoid arthritis-affected joints. Rheumatol Int 2008, 28(9):837-844.
18. Rice J.W., Veal J.M., Fadden R.P., Barabasz A.F., Partridge J.M., Barta T.E., et al. Small molecule inhibitors of Hsp90 potently affect inflammatory disease pathways and exhibit activity in models of rheumatoid arthritis. Arthritis Rheum 2008, 58(12):3765-3775.
19. Erlandsson Harris H., Liljestrom M., Klareskog L. Characteristics of synovial fluid effusion in collagen-induced arthritis (CIA) in the DA rat; a comparison of histology and antibody reactivities in an experimental chronic arthritis model and rheumatoid arthritis (RA). Clin Exp Immunol 1997, 107(3):480-484.
20. Bodman-Smith M.D., Corrigall V.M., Berglin E., Cornell H.R., Tzioufas A.G., Mavragani C.P., et al. Antibody response to the human stress protein BiP in rheumatoid arthritis. Rheumatology (Oxford) 2004, 43(10):1283-1287.
21. Zlacka D., Vavrincova P., Hien Nguyen T.T., Hromadnikova I. Frequency of anti-hsp60, -65 and -70 antibodies in sera of patients with juvenile idiopathic arthritis. J Autoimmun 2006, 27(2):81-88.
22. Kim H.R., Kim E.Y., Cerny J., Moudgil K.D. Antibody responses to mycobacterial and self heat shock protein 65 in autoimmune arthritis: epitope specificity and implication in pathogenesis. J Immunol 2006, 177(10):6634-6641.
23. Miletic T., Kovacevic-Jovanovic V., Stanojevic S., Vujic V., Kosec D., Mitic K., et al. Strain differences and the role for HSP47 and HSP70 in adjuvant arthritis in rats. Scand J Immunol 2006, 64(6):623-632.
24. Schultz D.R., Arnold P.I. Heat shock (stress) proteins and autoimmunity in rheumatic diseases. Semin Arthritis Rheum 1993, 22(6):357-374.
25. Pearson C.M. Development of arthritis, periarthritis and periostitis in rats given adjuvants. Proc Soc Exp Biol Med 1956, 91(1):95-101.
26. Wilder R.L. Streptococcal cell-wall-induced arthritis in rats: an overview. Int J Tissue React 1988, 10(1):1-5.
27. Song X.Y., Zeng L., Jin W., Pilo C.M., Frank M.E., Wahl S.M. Suppression of streptococcal cell wall-induced arthritis by human chorionic gonadotropin. Arthritis Rheum 2000, 43(9):2064-2072.
28. Thompson S.J., Francis J.N., Siew L.K., Webb G.R., Jenner P.J., Colston M.J., et al. An immunodominant epitope from mycobacterial 65-kDa heat shock protein protects against pristane-induced arthritis. J Immunol 1998, 160(9):4628-4634.
29. Kingston A.E., Hicks C.A., Colston M.J., Billingham M.E. A 71-kD heat shock protein (hsp) from Mycobacterium tuberculosis has modulatory effects on experimental rat arthritis. Clin Exp Immunol 1996, 103(1):77-82.
30. Prakken B.J., van der Zee R., Anderton S.M., van Kooten P.J., Kuis W., van Eden W. Peptide-induced nasal tolerance for a mycobacterial heat shock protein 60 T cell epitope in rats suppresses both adjuvant arthritis and nonmicrobially induced experimental arthritis. Proc Natl Acad Sci USA 1997, 94(7):3284-3289.
31. Wendling U., Paul L., van der Zee R., Prakken B., Singh M., van Eden W. A conserved mycobacterial heat shock protein (hsp) 70 sequence prevents adjuvant arthritis upon nasal administration and induces IL-10-producing T cells that cross-react with the mammalian self-hsp70 homologue. J Immunol 2000, 164(5):2711-2717.
32. Quintana F.J., Carmi P., Mor F., Cohen I.R. Inhibition of adjuvant-induced arthritis by DNA vaccination with the 70-kd or the 90-kd human heat-shock protein: immune cross-regulation with the 60-kd heat-shock protein. Arthritis Rheum 2004, 50(11):3712-3720.
33. Satpute S.R., Rajaiah R., Polumuri S.K., Moudgil K.D. Tolerization with Hsp65 induces protection against adjuvant-induced arthritis by modulating the antigen-directed interferon-gamma, interleukin-17, and antibody responses. Arthritis Rheum 2009, 60(1):103-113.
34. Ragno S., Winrow V.R., Mascagni P., Lucietto P., Di Pierro F., Morris C.J., et al. A synthetic 10-kD heat shock protein (hsp10) from Mycobacterium tuberculosis modulates adjuvant arthritis. Clin Exp Immunol 1996, 103(3):384-390.
35. Agnello D., Scanziani E., Di G.M., Leoni F., Modena D., Mascagni P., et al. Preventive administration of Mycobacterium tuberculosis 10-kDa heat shock protein (hsp10) suppresses adjuvant arthritis in Lewis rats. Int Immunopharmacol 2002, 2(4):463-474.
36. Brownlie R.J., Myers L.K., Wooley P.H., Corrigall V.M., Bodman-Smith M.D., Panayi G.S., et al. Treatment of murine collagen-induced arthritis by the stress protein BiP via interleukin-4-producing regulatory T cells: a novel function for an ancient protein. Arthritis Rheum 2006, 54(3):854-863.
37. Jorgensen C., Gedon E., Jaquet C., Sany J. Gastric administration of recombinant 65 kDa heat shock protein delays the severity of type II collagen induced arthritis in mice. J Rheumatol 1998, 25(4):763-767.
38. Xiao J., Li S., Wang W., Li Y., Zhao W. Protective effects of overexpression TCR Vbeta5.2-HSP70 and TCR Vbeta8.2-HSP70 against collagen-induced arthritis in rats. Cell Mol Immunol 2007, 4(6):439-445.
39. Anderton S.M., van der Zee R., Noordzij A., van Eden W. Differential mycobacterial 65-kDa heat shock protein T cell epitope recognition after adjuvant arthritis-inducing or protective immunization protocols. J Immunol 1994, 152(7):3656-3664.
40. Anderton S.M., van der Zee R., Prakken B., Noordzij A., van Eden W. Activation of T cells recognizing self 60-kD heat shock protein can protect against experimental arthritis. J Exp Med 1995, 181(3):943-952.
41. Durai M., Kim H.R., Moudgil K.D. The regulatory C-terminal determinants within mycobacterial heat shock protein 65 are cryptic and cross-reactive with the dominant self homologs: implications for the pathogenesis of autoimmune arthritis. J Immunol 2004, 173(1):181-188.
42. Wendling U., Bloemendal A., Van Der Zee R., Rutten V.P., Van Kooten P.J., Farine J.C., et al. Antirheumatic E. coli extract OM-89 induces T cell responses to HSP60 and 70. Int J Immunopharmacol 1997, 19(9-10):565-568.
43. Durai M., Gupta R.S., Moudgil K.D. The T cells specific for the carboxyl-terminal determinants of self (rat) heat-shock protein 65 escape tolerance induction and are involved in regulation of autoimmune arthritis. J Immunol 2004, 172(5):2795-2802.
44. Billingham M.E., Carney S., Butler R., Colston M.J. A mycobacterial 65-kD heat shock protein induces antigen-specific suppression of adjuvant arthritis, but is not itself arthritogenic. J Exp Med 1990, 171(1):339-344.
45. Kohashi O., Kohashi Y., Takahashi T., Ozawa A., Shigematsu N. Reverse effect of gram-positive bacteria vs. gram-negative bacteria on adjuvant-induced arthritis in germfree rats. Microbiol Immunol 1985, 29(6):487-497.
46. Kohashi O., Kohashi Y., Takahashi T., Ozawa A., Shigematsu N. Suppressive effect of Escherichia coli on adjuvant-induced arthritis in germ-free rats. Arthritis Rheum 1986, 29(4):547-553.
47. Quadri S.A., Taneja V., Mehra N.K., Singal D.P. HSP70-1 promoter region alleles and susceptibility to rheumatoid arthritis. Clin Exp Rheumatol 1996, 14(2):183-185.
48. Rueda B., Oliver J., Robledo G., Lopez-Nevot M.A., Balsa A., Pascual-Salcedo D., et al. HO-1 promoter polymorphism associated with rheumatoid arthritis. Arthritis Rheum 2007, 56(12):3953-3958.
49. Singal D.P., Li J., Zhu Y. HLA class III region and susceptibility to rheumatoid arthritis. Clin Exp Rheumatol 2000, 18(4):485-491.
50. Wagener F.A., Toonen E.J., Wigman L., Fransen J., Creemers M.C., Radstake T.R., et al. HMOX1 promoter polymorphism modulates the relationship between disease activity and joint damage in rheumatoid arthritis. Arthritis Rheum 2008, 58(11):3388-3393.
51. Jenkins S.C., March R.E., Campbell R.D., Milner C.M. A novel variant of the MHC-linked hsp70, hsp70-hom, is associated with rheumatoid arthritis. Tissue Antigens 2000, 56(1):38-44.
52. Jacq L., Teixeira V.H., Garnier S., Michou L., Dieude P., Rocha D., et al. HSPD1 is not a major susceptibility gene for rheumatoid arthritis in the French Caucasian population. J Hum Genet 2007, 52(12):1036-1039.
53. Vinasco J., Beraun Y., Nieto A., Fraile A., Pareja E., Mataran L., et al. Heat shock protein 70 gene polymorphisms in rheumatoid arthritis. Tissue Antigens 1997, 50(1):71-73.
54. Auger I., Escola J.M., Gorvel J.P., Roudier J. HLA-DR4 and HLA-DR10 motifs that carry susceptibility to rheumatoid arthritis bind 70-kD heat shock proteins. Nat Med 1996, 2(3):306-310.
55. Albani S., Tuckwell J.E., Esparza L., Carson D.A., Roudier J. The susceptibility sequence to rheumatoid arthritis is a cross-reactive B cell epitope shared by the Escherichia coli heat shock protein dnaJ and the histocompatibility leukocyte antigen DRB10401 molecule. J Clin Invest 1992, 89(1):327-331.
56. Auger I., Lepecuchel L., Roudier J. Interaction between heat-shock protein 73 and HLA-DRB1 alleles associated or not with rheumatoid arthritis. Arthritis Rheum 2002, 46(4):929-933.
57. Auger I., Roudier J. A function for the QKRAA amino acid motif: mediating binding of DnaJ to DnaK. Implications for the association of rheumatoid arthritis with HLA-DR4. J Clin Invest 1997, 99(8):1818-1822.
58. Albani S., Keystone E.C., Nelson J.L., Ollier W.E., La Cava A., Montemayor A.C., et al. Positive selection in autoimmunity: abnormal immune responses to a bacterial dnaJ antigenic determinant in patients with early rheumatoid arthritis. Nat Med 1995, 1(5):448-452.
59. Maier J.T., Haug M., Foll J.L., Beck H., Kalbacher H., Rammensee H.G., et al. Possible association of non-binding of HSP70 to HLA-DRB1 peptide sequences and protection from rheumatoid arthritis. Immunogenetics 2002, 54(2):67-73.
60. Alcaraz M.J., Fernandez P., Guillen M.I. Anti-inflammatory actions of the heme oxygenase-1 pathway. Curr Pharm Des 2003, 9(30):2541-2551.
61. Huang Q.Q., Sobkoviak R., Jockheck-Clark A.R., Shi B., Mandelin A.M., Tak P.P., et al. Heat shock protein 96 is elevated in rheumatoid arthritis and activates macrophages primarily via TLR2 signaling. J Immunol 2009, 182(8):4965-4973.
62. Nanke Y., Kawamoto M., Yago T., Chiba J., Yamanaka H., Kotake S. Geranylgeranylacetone, a non-toxic inducer of heat shock protein, induces cell death in fibroblast-like synoviocytes from patients with rheumatoid arthritis. Mod Rheumatol 2009, 19(4):379-383.
63. Burmester G.R., Altstidl U., Kalden J.R., Emmrich F. Stimulatory response towards the 65 kDa heat shock protein and other mycobacterial antigens in patients with rheumatoid arthritis. J Rheumatol 1991, 18(2):171-176.
64. Celis L., Vandevyver C., Geusens P., Dequeker J., Raus J., Zhang J. Clonal expansion of mycobacterial heat-shock protein-reactive T lymphocytes in the synovial fluid and blood of rheumatoid arthritis patients. Arthritis Rheum 1997, 40(3):510-519.
65. Gaston J.S., Life P.F., van der Zee R., Jenner P.J., Colston M.J., Tonks S., et al. Epitope specificity and MHC restriction of rheumatoid arthritis synovial T cell clones which recognize a mycobacterial 65 kDa heat shock protein. Int Immunol 1991, 3(10):965-972.
66. Kogure A., Miyata M., Nishimaki T., Kasukawa R. Proliferative response of synovial fluid mononuclear cells of patients with rheumatoid arthritis to mycobacterial 65 kDa heat shock protein and its association with HLA-DR+.gamma delta+ T cells. J Rheumatol 1994, 21(8):1403-1408.
67. Lai N.S., Lan J.L., Yu C.L., Lin R.H. A dominant human leucocyte antigen DR4-Dw15 restricted mycobacterial 65 kDa antigen-specific T-cell immunity in Chinese patients with rheumatoid arthritis. Br J Rheumatol 1995, 34(6):498-506.
68. MacHt L.M., Elson C.J., Kirwan J.R., Gaston J.S., Lamont A.G., Thompson J.M., et al. Relationship between disease severity and responses by blood mononuclear cells from patients with rheumatoid arthritis to human heat-shock protein 60. Immunology 2000, 99(2):208-214.
69. Melchers I., Jooss-Rudiger J., Peter H.H. Reactivity patterns of synovial T-cell lines derived from a patient with rheumatoid arthritis. I. Reactions with defined antigens and auto-antigens suggest the existence of multireactive T-cell clones. Scand J Immunol 1997, 46(2):187-194.
70. Pope R.M., Lovis R.M., Gupta R.S. Activation of synovial fluid T lymphocytes by 60-kd heat-shock proteins in patients with inflammatory synovitis. Arthritis Rheum 1992, 35(1):43-48.
71. Bahr G.M., Rook G.A., al-Saffar M., Van Embden J., Stanford J.L., Behbehani K. Antibody levels to mycobacteria in relation to HLA type: evidence for non-HLA-linked high levels of antibody to the 65 kD heat shock protein of M. bovis in rheumatoid arthritis. Clin Exp Immunol 1988, 74(2):211-215.
72. van Roon J.A., van Eden W., van Roy J.L., Lafeber F.J., Bijlsma J.W. Stimulation of suppressive T cell responses by human but not bacterial 60-kD heat-shock protein in synovial fluid of patients with rheumatoid arthritis. J Clin Invest 1997, 100(2):459-463.
73. Gaston J.S., Life P.F., Bailey L.C., Bacon P.A. In vitro responses to a 65-kilodalton mycobacterial protein by synovial T cells from inflammatory arthritis patients. J Immunol 1989, 143(8):2494-2500.
74. Li S.G., Quayle A.J., Shen Y., Kjeldsen-Kragh J., Oftung F., Gupta R.S., et al. Mycobacteria and human heat shock protein-specific cytotoxic T lymphocytes in rheumatoid synovial inflammation. Arthritis Rheum 1992, 35(3):270-281.
75. Prakken B.J., Samodal R., Le T.D., Giannoni F., Yung G.P., Scavulli J., et al. Epitope-specific immunotherapy induces immune deviation of proinflammatory T cells in rheumatoid arthritis. Proc Natl Acad Sci USA 2004, 101(12):4228-4233.
76. Blass S., Union A., Raymackers J., Schumann F., Ungethum U., Muller-Steinbach S., et al. The stress protein BiP is overexpressed and is a major B and T cell target in rheumatoid arthritis. Arthritis Rheum 2001, 44(4):761-771.
77. Corrigall V.M., Bodman-Smith M.D., Fife M.S., Canas B., Myers L.K., Wooley P., et al. The human endoplasmic reticulum molecular chaperone BiP is an autoantigen for rheumatoid arthritis and prevents the induction of experimental arthritis. J Immunol 2001, 166(3):1492-1498.
78. Zou J., Rudwaleit M., Thiel A., Lauster R., Braun J., Sieper J. T cell response to human HSP60 and yersinia 19 kDa in ankylosing spondylitis and rheumatoid arthritis: no evidence for a causal role of these antigens in the pathogenesis. Ann Rheum Dis 2002, 61(5):473-474.
79. Crick F.D., Gatenby P.A. Limiting-dilution analysis of T cell reactivity to mycobacterial antigens in peripheral blood and synovium from rheumatoid arthritis patients. Clin Exp Immunol 1992, 88(3):424-429.
80. Fischer H.P., Sharrock C.E., Colston M.J., Panayi G.S. Limiting dilution analysis of proliferative T cell responses to mycobacterial 65-kDa heat-shock protein fails to show significant frequency differences between synovial fluid and peripheral blood of patients with rheumatoid arthritis. Eur J Immunol 1991, 21(12):2937-2941.
81. Sheikhi A., Nazarian M., Khadem-Al-Melleh A., Nasab N.M., Esmaeilzadeh A., Yahaghi N., et al. In-vitro effects of Mycobacterium bovis BCG-lysate and its derived heat shock proteins on cytokines secretion by blood mononuclear cells of rheumatoid arthritis patients in comparison with healthy controls. Int Immunopharmacol 2008, 8(6):887-892.
82. Chukwuocha R.U., Zhang B., Lai C.J., Scavulli J.F., Albani S., Carson D.A., et al. Isolation of an IgG monoclonal anti-dnaJ antibody from an immunoglobulin combinatorial library from a patient with rheumatoid arthritis. J Rheumatol 1999, 26(7):1439-1445.
83. Yoshida A., Nakano Y., Yamashita Y., Oho T., Ito H., Kondo M., et al. Immunodominant region of Actinobacillus actinomycetemcomitans 40-kilodalton heat shock protein in patients with rheumatoid arthritis. J Dent Res 2001, 80(1):346-350.
84. Hattori T., Takahash K., Yutani Y., Fujisawa T., Nakanishi T., Takigawa M. Rheumatoid arthritis-related antigen 47kDa (RA-A47) is a product of colligin-2 and acts as a human HSP47. J Bone Miner Metab 2000, 18(6):328-334.
85. Sakawa A., Yutani Y., Inui K., Shimazu A., Yamano Y., Kinosita A., et al. Specific serum antibodies against membranous proteins of a human immortal chondrocytic cell line (HCS-2/8) in rheumatoid arthritis and their relationship to the natural history of this disease. J Bone Miner Metab 1996, 14(3):146-152.
86. Tsoulfa G., Rook G.A., Bahr G.M., Sattar M.A., Behbehani K., Young D.B., et al. Elevated IgG antibody levels to the mycobacterial 65-kDa heat shock protein are characteristic of patients with rheumatoid arthritis. Scand J Immunol 1989, 30(5):519-527.
87. Adebajo A.O., Williams D.G., Hazleman B.L., Maini R.N. Antibodies to the 65 kDa mycobacterial stress protein in west Africans with rheumatoid arthritis, tuberculosis and malaria. Br J Rheumatol 1995, 34(4):352-354.
88. Hirata D., Hirai I., Iwamoto M., Yoshio T., Takeda A., Masuyama J.I., et al. Preferential binding with Escherichia coli hsp60 of antibodies prevalent in sera from patients with rheumatoid arthritis. Clin Immunol Immunopathol 1997, 82(2):141-148.
89. Panchapakesan J., Daglis M., Gatenby P. Antibodies to 65 kDa and 70 kDa heat shock proteins in rheumatoid arthritis and systemic lupus erythematosus. Immunol Cell Biol 1992, 70(Pt. 5):295-300.
90. Rudolphi U., Rzepka R., Batsford S., Kaufmann S.H., von der Mark K., Peter H.H., et al. The B cell repertoire of patients with rheumatoid arthritis. II. Increased frequencies of IgG+ and IgA+ B cells specific for mycobacterial heat-shock protein 60 or human type II collagen in synovial fluid and tissue. Arthritis Rheum 1997, 40(8):1409-1419.
91. van Halm V.P., Slot M.C., Nurmohamed M.T., Cohen Tervaert J.W., Dijkmans B.A., Voskuyl A.E. Antibodies against human 60 kDa heat shock protein are not associated with cardiovascular disease in patients with rheumatoid arthritis. Ann Rheum Dis 2006, 65(5):590-594.
92. Oda A., Miyata M., Kodama E., Satoh H., Sato Y., Nishimaki T., et al. Antibodies to 65Kd heat-shock protein were elevated in rheumatoid arthritis. Clin Rheumatol 1994, 13(2):261-264.
93. Mavropoulos J.C., Cuchacovich M., Llanos C., Aguillon J.C., Gatica H., Pizzo S.V., et al. Anti-tumor necrosis factor-alpha therapy augments dipeptidyl peptidase IV activity and decreases autoantibodies to GRP78/BIP and phosphoglucose isomerase in patients with rheumatoid arthritis. J Rheumatol 2005, 32(11):2116-2124.
94. Hayem G., De Bandt M., Palazzo E., Roux S., Combe B., Eliaou J.F., et al. Anti-heat shock protein 70 kDa and 90 kDa antibodies in serum of patients with rheumatoid arthritis. Ann Rheum Dis 1999, 58(5):291-296.
95. McLean I.L., Archer J.R., Cawley M.I., Pegley F.S., Kidd B.L., Thompson P.W. Specific antibody response to the mycobacterial 65 kDa stress protein in ankylosing spondylitis and rheumatoid arthritis. Br J Rheumatol 1990, 29(6):426-429.
96. Rudolphi U., Hohlbaum A., Lang B., Peter H.H., Melchers I. The B cell repertoire of patients with rheumatoid arthritis. Frequencies and specificities of peripheral blood B cells reacting with human IgG, human collagens, a mycobacterial heat shock protein and other antigens. Clin Exp Immunol 1993, 92(3):404-411.
97. Sherer Y., Gerli R., Bocci E.B., Gilburd B., Vaudo G., Bistoni O., et al. Heat-shock protein 65 autoantibodies are differently associated with early atherosclerosis in rheumatoid arthritis and in healthy subjects. Ann NY Acad Sci 2007, 1108:408-413.
98. Worthington J., Rigby A.S., MacGregor A.J., Silman A.J., Carthy D., Ollier W.E. Lack of association of increased antibody levels to mycobacterial hsp65 with rheumatoid arthritis: results from a study of disease discordant twin pairs. Ann Rheum Dis 1993, 52(7):542-544.
99. Roelofs M.F., Boelens W.C., Joosten L.A., Abdollahi-Roodsaz S., Geurts J., Wunderink L.U., et al. Identification of small heat shock protein B8 (HSP22) as a novel TLR4 ligand and potential involvement in the pathogenesis of rheumatoid arthritis. J Immunol 2006, 176(11):7021-7027.
100. Kidd B.A., Ho P.P., Sharpe O., Zhao X., Tomooka B.H., Kanter J.L., et al. Epitope spreading to citrullinated antigens in mouse models of autoimmune arthritis and demyelination. Arthritis Res Ther 2008, 10(5):R119.
101. Nielen M.M., van Schaardenburg D., Reesink H.W., van de Stadt R.J., van der Horst-Bruinsma I.E., de Koning M.H., et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum 2004, 50(2):380-386.
102. Quinn M.A., Gough A.K., Green M.J., Devlin J., Hensor E.M., Greenstein A., et al. Anti-CCP antibodies measured at disease onset help identify seronegative rheumatoid arthritis and predict radiological and functional outcome. Rheumatology (Oxford) 2006, 45(4):478-480.
103. Kobayashi H., Takeno M., Saito T., Takeda Y., Kirino Y., Noyori K., et al. Regulatory role of heme oxygenase 1 in inflammation of rheumatoid arthritis. Arthritis Rheum 2006, 54(4):1132-1142.
104. Vanags D., Williams B., Johnson B., Hall S., Nash P., Taylor A., et al. Therapeutic efficacy and safety of chaperonin 10 in patients with rheumatoid arthritis: a double-blind randomised trial. Lancet 2006, 368(9538):855-863.
105. Johnson B.J., Le T.T., Dobbin C.A., Banovic T., Howard C.B., Flores Fde M., et al. Heat shock protein 10 inhibits lipopolysaccharide-induced inflammatory mediator production. J Biol Chem 2005, 280(6):4037-4047.
106. van den Broek T.K.E., van Wijk F., Ghahramani N., Schechter N., van de Ven A., Albani S. Susceptibility to epitope specific immunotherapy of rheumatoid arthritis relies on the expression of co-stimulatory molecules associated with T cells anergy and tolerance (Abstract number 1848), Abstract supplement 2008 Annual Scientific Meeting. Arthritis Rheum 2008, 58(Suppl 9):845.
107. Ehrenstein M.R., Evans J.G., Singh A., Moore S., Warnes G., Isenberg D.A., et al. Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy. J Exp Med 2004, 200(3):277-285.
108. Zanin-Zhorov A., Cahalon L., Tal G., Margalit R., Lider O., Cohen I.R. Heat shock protein 60 enhances CD4+ CD25+ regulatory T cell function via innate TLR2 signaling. J Clin Invest 2006, 116(7):2022-2032.
109. De Graeff-Meeder E.R., van der Zee R., Rijkers G.T., Schuurman H.J., Kuis W., Bijlsma J.W., et al. Recognition of human 60 kD heat shock protein by mononuclear cells from patients with juvenile chronic arthritis. Lancet 1991, 337(8754):1368-1372.
110. de Graeff-Meeder E.R., van Eden W., Rijkers G.T., Prakken B.J., Kuis W., Voorhorst-Ogink M.M., et al. Juvenile chronic arthritis: T cell reactivity to human HSP60 in patients with a favorable course of arthritis. J Clin Invest 1995, 95(3):934-940.
111. de Kleer I.M., Kamphuis S.M., Rijkers G.T., Scholtens L., Gordon G., De Jager W., et al. The spontaneous remission of juvenile idiopathic arthritis is characterized by CD30+ T cells directed to human heat-shock protein 60 capable of producing the regulatory cytokine interleukin-10. Arthritis Rheum 2003, 48(7):2001-2010.
112. Prakken A.B., van Eden W., Rijkers G.T., Kuis W., Toebes E.A., de Graeff-Meeder E.R., et al. Autoreactivity to human heat-shock protein 60 predicts disease remission in oligoarticular juvenile rheumatoid arthritis. Arthritis Rheum 1996, 39(11):1826-1832.
113. Kim E.Y., Moudgil K.D. The determinants of susceptibility/resistance to adjuvant arthritis in rats. Arthritis Res Ther 2009, 11(4):239.
114. Edwards C.J. Commensal gut bacteria and the etiopathogenesis of rheumatoid arthritis. J Rheumatol 2008, 35(8):1477-1497.
115. Barclay A.R., Morrison D.J., Weaver L.T. What is the role of the metabolic activity of the gut microbiota in inflammatory bowel disease?. Probing for answers with stable isotopes. J Pediatr Gastroenterol Nutr 2008, 46(5):486-495.
116. Vaahtovuo J., Munukka E., Korkeamaki M., Luukkainen R., Toivanen P. Fecal microbiota in early rheumatoid arthritis. J Rheumatol 2008, 35(8):1500-1505.
117. Breban M.A., Moreau M.C., Fournier C., Ducluzeau R., Kahn M.F. Influence of the bacterial flora on collagen-induced arthritis in susceptible and resistant strains of rats. Clin Exp Rheumatol 1993, 11(1):61-64.
118. Moudgil K.D., Kim E., Yun O.J., Chi H.H., Brahn E., Sercarz E.E. Environmental modulation of autoimmune arthritis involves the spontaneous microbial induction of T cell responses to regulatory determinants within heat shock protein 65. J Immunol 2001, 166(6):4237-4243.
119. Toivanen P., Vaahtovuo J., Eerola E. Influence of major histocompatibility complex on bacterial composition of fecal flora. Infect Immun 2001, 69(4):2372-2377.
120. Khachatryan Z.A., Ktsoyan Z.A., Manukyan G.P., Kelly D., Ghazaryan K.A., Aminov R.I. Predominant role of host genetics in controlling the composition of gut microbiota. PLoS One 2008, 3(8):e3064.
121. Clayton T.A., Baker D., Lindon J.C., Everett J.R., Nicholson J.K. Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism. Proc Natl Acad Sci USA 2009, 106(34):14728-14733.
122. Hogervorst E.J., Schouls L., Wagenaar J.P., Boog C.J., Spaan W.J., et al. Modulation of experimental autoimmunity: treatment of adjuvant arthritis by immunization with a recombinant vaccinia virus. Infect Immun 1991, 59(6):2029-2035.
123. Devesa I., Ferrandiz M.L., Busserolles J., Alcaraz M.J. Effects of heme oxygenase-1 inducers on established rat adjuvant arthritis. Cell Mol Biol (Noisy-le-grand) 2005, 51(5):479-485.
124. Bloemendal A., Van der Zee R., Rutten V.P., van Kooten P.J., Farine J.C., van Eden W. Experimental immunization with anti-rheumatic bacterial extract OM-89 induces T cell responses to heat shock protein (hsp)60 and hsp70; modulation of peripheral immunological tolerance as its possible mode of action in the treatment of rheumatoid arthritis (RA). Clin Exp Immunol 1997, 110(1):72-78.
125. Lopez-Guerrero J.A., Ortiz M.A., Paez E., Bernabeu C., Lopez-Bote J.P. Therapeutic effect of recombinant vaccinia virus expressing the 60-kd heat-shock protein on adjuvant arthritis. Arthritis Rheum 1994, 37(10):1462-1467.
126. Prakken B.J., Wendling U., van der Zee R., Rutten V.P., Kuis W., van Eden W. Induction of IL-10 and inhibition of experimental arthritis are specific features of microbial heat shock proteins that are absent for other evolutionarily conserved immunodominant proteins. J Immunol 2001, 167(8):4147-4153.
127. Sugita T., Tanaka S., Murakami T., Miyoshi H., Ohnuki T. Immunosuppressive effects of the heat shock protein 90-binding antibiotic geldanamycin. Biochem Mol Biol Int 1999, 47(4):587-595.
128. Barker R.N., Webb G.R., Thompson S.J., Ghoraishian M., Ponsford F.M., Elson C.J. Differential effects of immunisation with mycobacterial 65 kD heat shock protein on two models of autoimmunity. Autoimmunity 1992, 14(1):73-77.
129. Beech J.T., Siew L.K., Ghoraishian M., Stasiuk L.M., Elson C.J., Thompson S.J. CD4+ Th2 cells specific for mycobacterial 65-kilodalton heat shock protein protect against pristine-induced arthritis. J Immunol 1997, 159(8):3692-3697.
130. Ghoraishian M., Elson C.J., Thompson S.J. Comparison between the protective effects of mycobacterial 65-kD heat shock protein and ovomucoid in pristane-induced arthritis: relationship with agalactosyl IgG. Clin Exp Immunol 1993, 94(2):247-251.
131. Santos-Junior R.R., Sartori A., De Franco M., Filho O.G., Coelho-Castelo A.A., Bonato V.L., et al. Immunomodulation and protection induced by DNA-hsp65 vaccination in an animal model of arthritis. Hum Gene Ther 2005, 16(11):1338-1345.
132. Thompson S.J., Hitsumoto Y., Ghoraishian M., van der Zee R., Elson C.J. Cellular and humoral reactivity pattern to the mycobacterial heat shock protein hsp65 in pristane induced arthritis susceptible and hsp65 protected DBA/1 mice. Autoimmunity 1991, 11(2):89-95.
133. Willis D., Moore A.R., Gowland G., Willoughby A. Polyarthritis in the rat: effects of tolerance and sensitization to the bacterial extract OM-89 with a possible mode of action. Br J Rheumatol 1995, 34(12):1135-1138.
134. Wieten L., Berlo S.E., Ten Brink C.B., van Kooten P.J., Singh M., van der Zee R., et al. IL-10 is critically involved in mycobacterial HSP70 induced suppression of proteoglycan-induced arthritis. PLoS ONE 2009, 4(1):e4186.
135. Golden H.W., Maniglia C.A., Ranges G.E. A synthetic mycobacterial heat shock peptide prevents adjuvant arthritis but not proteoglycan-induced synovitis in the rat. Agents Actions 1991, 34(1-2):148-150.
136. Hunt D.W., Corson L., Barker H.D., Levy J.G., Petty R.E. Relationship between collagen-induced and adjuvant arthritis in the Lewis rat. J Autoimmun 1993, 6(6):691-700.
137. Kurzik-Dumke U., Schick C., Rzepka R., Melchers I. Overexpression of human homologs of the bacterial DnaJ chaperone in the synovial tissue of patients with rheumatoid arthritis. Arthritis Rheum 1999, 42(2):210-220.
138. Dasuri K., Antonovici M., Chen K., Wong K., Standing K., Ens W., et al. The synovial proteome: analysis of fibroblast-like synoviocytes. Arthritis Res Ther 2004, 6(2):R161-R168.
139. Kodama E., Kasukawa R., Miyata M., Shigeta S., Ito M. Analysis of human 65 kD heat shock protein mRNA using polymerase chain reaction in synovia of rheumatoid arthritis patients. Fukushima J Med Sci 1995, 41(2):95-102.
140. Sharif M., Worrall J.G., Singh B., Gupta R.S., Lydyard P.M., Lambert C., et al. The development of monoclonal antibodies to the human mitochondrial 60-kd heat-shock protein, and their use in studying the expression of the protein in rheumatoid arthritis. Arthritis Rheum 1992, 35(12):1427-1433.
141. Karlsson-Parra A., Soderstrom K., Ferm M., Ivanyi J., Kiessling R., Klareskog L. Presence of human 65 kD heat shock protein (hsp) in inflamed joints and subcutaneous nodules of RA patients. Scand J Immunol 1990, 31(6):283-288.
142. de Graeff-Meeder E.R., Voorhorst M., van Eden W., Schuurman H.J., Huber J., Barkley D., et al. Antibodies to the mycobacterial 65-kd heat-shock protein are reactive with synovial tissue of adjuvant arthritic rats and patients with rheumatoid arthritis and osteoarthritis. Am J Pathol 1990, 137(5):1013-1017.
143. Martin C.A., Carsons S.E., Kowalewski R., Bernstein D., Valentino M., Santiago-Schwarz F. Aberrant extracellular and dendritic cell (DC) surface expression of heat shock protein (hsp)70 in the rheumatoid joint: possible mechanisms of hsp/DC-mediated cross-priming. J Immunol 2003, 171(11):5736-5742.
144. Nguyen T.T., Gehrmann M., Zlacka D., Sosna A., Vavrincova P., Multhoff G., et al. Heat shock protein 70 membrane expression on fibroblast-like synovial cells derived from synovial tissue of patients with rheumatoid and juvenile idiopathic arthritis. Scand J Rheumatol 2006, 35(6):447-453.
145. Schett G., Redlich K., Xu Q., Bizan P., Groger M., Tohidast-Akrad M., et al. Enhanced expression of heat shock protein 70 (hsp70) and heat shock factor 1 (HSF1) activation in rheumatoid arthritis synovial tissue. Differential regulation of hsp70 expression and hsf1 activation in synovial fibroblasts by proinflammatory cytokines, shear stress, and antiinflammatory drugs. J Clin Invest 1998, 102(2):302-311.
146. Dong W., Li X., Feng Y., Fan C., Chen Z., Zhu P. The differential expressions of 78-kDa glucose regulated protein of infiltrating plasma cells in peripheral joints with the histopathological variants of rheumatoid synovitis. Arthritis Res Ther 2009, 11(1):R4.
147. Schick C., Arbogast M., Lowka K., Rzepka R., Melchers I. Continuous enhanced expression of Hsc70 but not Hsp70 in rheumatoid arthritis synovial tissue. Arthritis Rheum 2004, 50(1):88-93.
148. Sato H., Miyata M., Kasukawa R. Expression of heat shock protein on lymphocytes in peripheral blood and synovial fluid from patients with rheumatoid arthritis. J Rheumatol 1996, 23(12):2027-2032.
149. Kanerud L., Scheynius A., Nord C.E., Hafstrom I. Effect of sulphasalazine on gastrointestinal microflora and on mucosal heat shock protein expression in patients with rheumatoid arthritis. Br J Rheumatol 1994, 33(11):1039-1048.